Switch theme
Sign up to access all valuation multiples
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the US, and 35% in Europe.
1934
38K+
LTM Revenue $6.2B
LTM EBITDA $1.1B
$11.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Sonic Healthcare has a last 12-month revenue (LTM) of $6.2B and a last 12-month EBITDA of $1.1B.
In the most recent fiscal year, Sonic Healthcare achieved revenue of $5.7B and an EBITDA of $1.1B.
Sonic Healthcare expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Sonic Healthcare valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $6.2B | XXX | $5.7B | XXX | XXX | XXX |
| Gross Profit | $5.2B | XXX | $4.8B | XXX | XXX | XXX |
| Gross Margin | 84% | XXX | 84% | XXX | XXX | XXX |
| EBITDA | $1.1B | XXX | $1.1B | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 19% | XXX | XXX | XXX |
| EBIT | $592M | XXX | $524M | XXX | XXX | XXX |
| EBIT Margin | 10% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $339M | XXX | $328M | XXX | XXX | XXX |
| Net Margin | 5% | XXX | 6% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $3.2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Sonic Healthcare's stock price is AUD 27 (or $17).
Sonic Healthcare has current market cap of AUD 12.8B (or $8.2B), and EV of AUD 17.1B (or $11.0B).
See Sonic Healthcare trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $11.0B | $8.2B | XXX | XXX | XXX | XXX | $0.70 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Sonic Healthcare has market cap of $8.2B and EV of $11.0B.
Sonic Healthcare's trades at 1.8x EV/Revenue multiple, and 10.0x EV/EBITDA.
Equity research analysts estimate Sonic Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Sonic Healthcare has a P/E ratio of 24.3x.
See valuation multiples for Sonic Healthcare and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $8.2B | XXX | $8.2B | XXX | XXX | XXX |
| EV (current) | $11.0B | XXX | $11.0B | XXX | XXX | XXX |
| EV/Revenue | 1.8x | XXX | 1.8x | XXX | XXX | XXX |
| EV/EBITDA | 9.8x | XXX | 10.0x | XXX | XXX | XXX |
| EV/EBIT | 18.5x | XXX | 19.6x | XXX | XXX | XXX |
| EV/Gross Profit | 2.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | 24.3x | XXX | 24.6x | XXX | XXX | XXX |
| EV/FCF | 18.5x | XXX | 23.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSonic Healthcare's last 12 month revenue growth is 9%
Sonic Healthcare's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Sonic Healthcare's rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Sonic Healthcare's rule of X is 42% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Sonic Healthcare and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | 11% | XXX | 5% | XXX | XXX | XXX |
| Rule of 40 | 29% | XXX | 28% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 42% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 75% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Bangkok Dusit Medical Services | XXX | XXX | XXX | XXX | XXX | XXX |
| Syngene International | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Sonic Healthcare acquired XXX companies to date.
Last acquisition by Sonic Healthcare was XXXXXXXX, XXXXX XXXXX XXXXXX . Sonic Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Sonic Healthcare founded? | Sonic Healthcare was founded in 1934. |
| Where is Sonic Healthcare headquartered? | Sonic Healthcare is headquartered in Australia. |
| How many employees does Sonic Healthcare have? | As of today, Sonic Healthcare has 38K+ employees. |
| Who is the CEO of Sonic Healthcare? | Sonic Healthcare's CEO is Dr. Colin S Goldschmidt. |
| Is Sonic Healthcare publicy listed? | Yes, Sonic Healthcare is a public company listed on ASX. |
| What is the stock symbol of Sonic Healthcare? | Sonic Healthcare trades under SHL ticker. |
| When did Sonic Healthcare go public? | Sonic Healthcare went public in 1987. |
| Who are competitors of Sonic Healthcare? | Similar companies to Sonic Healthcare include e.g. Australian Clinical Labs, Healius, Integral Diagnostics, Bangkok Dusit Medical Services. |
| What is the current market cap of Sonic Healthcare? | Sonic Healthcare's current market cap is $8.2B |
| What is the current revenue of Sonic Healthcare? | Sonic Healthcare's last 12 months revenue is $6.2B. |
| What is the current revenue growth of Sonic Healthcare? | Sonic Healthcare revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Sonic Healthcare? | Current revenue multiple of Sonic Healthcare is 1.8x. |
| Is Sonic Healthcare profitable? | Yes, Sonic Healthcare is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Sonic Healthcare? | Sonic Healthcare's last 12 months EBITDA is $1.1B. |
| What is Sonic Healthcare's EBITDA margin? | Sonic Healthcare's last 12 months EBITDA margin is 18%. |
| What is the current EV/EBITDA multiple of Sonic Healthcare? | Current EBITDA multiple of Sonic Healthcare is 9.8x. |
| What is the current FCF of Sonic Healthcare? | Sonic Healthcare's last 12 months FCF is $593M. |
| What is Sonic Healthcare's FCF margin? | Sonic Healthcare's last 12 months FCF margin is 10%. |
| What is the current EV/FCF multiple of Sonic Healthcare? | Current FCF multiple of Sonic Healthcare is 18.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
